As approvals roll in, Takeda details pricing strategy for dengue vaccine launch zbecker Tue, 03/21/2023 – 10:40 More: As approvals roll in, Takeda details pricing strategy for dengue vaccine launch Source: fierce
read moreBaxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business: Reuters aliu Tue, 03/21/2023 – 10:12 More: Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business: Reuters Source: fierce
read moreDespite CMS snub, Eisai is ‘not so nervous’ about Leqembi’s long-term coverage prospects: US CEO fkansteiner Tue, 03/21/2023 – 09:41 More: Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO Source: fierce
read moreCompany raises €12m in financing with a view to entering to the European market More: Vitestro raises vital funding for autonomous blood drawing device Source: News
read moreResearch data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer More: Astellas and Pfizer reveal positive results for Xtandi Source: News
read moreAAD: Awaiting FDA decision in psoriasis, UCB touts 48-week data for bimekizumab in hidradenitis suppurativa zbecker Mon, 03/20/2023 – 11:19 More: AAD: Awaiting FDA decision in psoriasis, UCB touts 48-week data for bimekizumab in hidradenitis suppurativa Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals